Related Experiment Video
Updated: May 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in
Norihisa Toh1, Nobuhiro Nishii, Kazufumi Nakamura
1Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. nori-t@fd5.so-net.ne.jp
Insights
Implantable cardioverter-defibrillator shocks temporarily reduce cardiac function, particularly in patients with systolic dysfunction. However, no significant tissue damage was observed following the procedure.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Physiology
Background:
- Investigating acute effects of implantable cardioverter-defibrillator (ICD) shock on cardiac function and hemodynamics.
- Assessing the impact in relation to left ventricular systolic function.
Purpose of the Study:
- To evaluate the immediate consequences of ICD shock on myocardial function and hemodynamics.
- To compare these effects between patients with preserved and reduced left ventricular ejection fraction (LVEF).
Main Methods:
- Studied 50 patients undergoing ICD implantation and defibrillation threshold (DFT) testing.
- Measured cardiac biomarkers and assessed left ventricular relaxation using echocardiography.
- Monitored hemodynamic parameters and LVEF before and after DFT testing.
Main Results:
- No significant changes in cardiac biomarkers were observed.
- LVEF transiently decreased in patients with reduced LVEF post-shock, recovering within 4 hours.
- Left ventricular relaxation was impaired transiently in both groups post-shock.
Conclusions:
- ICD shock transiently impairs cardiac function and hemodynamics, especially in patients with systolic dysfunction.
- Significant myocardial tissue injury was not observed after ICD shock.
Background:
We investigated the acute effects of implantable cardioverter-defibrillator shock on myocardium, cardiac function, and hemodynamics in relation to left ventricular systolic function.
Methods And Results:
We studied 50 patients who underwent implantable cardioverter-defibrillator implantation and defibrillation threshold (DFT) testing: 25 patients with left ventricular ejection fraction (LVEF) ≥ 45% and 25 patients with LVEF <45%. We measured cardiac biomarkers (creatine kinase, creatine kinase-MB, myoglobin, cardiac troponin T and I, and N-terminal probrain natriuretic peptide). Left ventricular relaxation was assessed by global longitudinal strain rate during the isovolumetric relaxation period using speckle-tracking echocardiography. Blood sampling and echocardiography were performed before, immediately after, and 5 minutes and 4 hours after DFT testing. Mean arterial pressure was measured directly during DFT testing. Cardiac biomarkers showed no significant changes in either group. LVEF was decreased until 5 minutes after DFT testing and had recovered to the baseline at 4 hours in the group with reduced LVEF (P<0.001), whereas LVEF reduction was not observed in the group with preserved LVEF (P=0.637). Global isovolumetric relaxation period was decreased until 5 minutes after DFT testing and had recovered to the baseline at 4 hours in both groups (preserved LVEF: 0.39 ± 0.14 versus 0.23 ± 0.13* versus 0.23 ± 0.13* versus 0.40 ± 0.13 s(-1), *P<0.001 versus baseline; reduced LVEF: 0.15 ± 0.05 versus 0.08 ± 0.04† versus 0.09 ± 0.04† versus 0.15 ± 0.05 s(-1), †P<0.001 versus baseline, repeated-measures ANOVA). Time to recovery of mean arterial pressure to the baseline was prolonged in the group with reduced LVEF (P<0.001).
Conclusions:
Implantable cardioverter-defibrillator shock transiently impairs cardiac function and hemodynamics especially in patients with systolic dysfunction, although significant tissue injury is not observed.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology

